KAMERON KLOSTERMAN: Open Payments
NPI 1609984715 · PACOLET, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 29 payments from 10 companies in 2025. Trend: 2023 $566 · 2024 $483 · 2025 $590
Food & beverage: $515Education: $75
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $189 |
| ABBVIE INC. | 5 | $79 |
| Lilly USA, LLC | 4 | $74 |
| Novo Nordisk Inc | 5 | $71 |
| Amgen Inc. | 4 | $59 |
| Dexcom, Inc. | 1 | $40 |
| Stryker Corporation | 1 | $27 |
| PFIZER INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Veozah, MOUNJARO, VRAYLAR, EVENITY, Rybelsus, Dexcom G6 Transmitter, Ozempic, FLOWTRIEVER CATHETER, S.
Industry payments across SC — which companies pay providers there.
